Abstract

The drug development process for Coronavirus disease (COVID-19) is the research process to create a preventive vaccine or therapeutic prescription drug to relieve the severity of 2019–2020 (COVID-19). In different stages of preclinical or clinical research, several hundred special scientific research centers, research organizations, and health agencies have developed and tried enormous numbers of vaccine candidates and new drugs for COVID-19 disease. In order to identify new therapies against COVID-19, several clinical trials have been in progress worldwide.

中文翻译：

---

可能用于治疗 COVID-19 患者的药物

摘要

冠状病毒病 (COVID-19) 的药物开发过程是开发预防性疫苗或治疗性处方药以减轻 2019-2020 年 (COVID-19) 严重性的研究过程。在临床前或临床研究的不同阶段，数百个专门的科学研究中心、研究机构和卫生机构已经开发和试用了大量针对 COVID-19 疾病的候选疫苗和新药。为了确定针对 COVID-19 的新疗法，全球范围内正在进行多项临床试验。